P8A:SGX
Cordlife Group Ltd
SGD 0,12
0,00%
(0,00) 1D
12 okt, 09:49:20 GMT+8 · SGD
search
Alle symbolen
| Symbool | Prijs | Wijziging | Wijzigingspercentage |
|---|
insights_autoBelangrijkste inzichten voor P8A genereren…
Beursw.
32,37 mln.
Gem. vol.
1,32K
Volume
0,00
52 wk hoog
SGD 0,26
52 wk laag
SGD 0,10
WPA
SGD -0,04
Uitstaande aandelen
267,53 mln.
Aantal medewerkers
111
Beursw.
32,37 mln.
Gem. vol.
1,32K
Volume
0,00
52 wk hoog
SGD 0,26
52 wk laag
SGD 0,10
WPA
SGD -0,04
Uitstaande aandelen
267,53 mln.
Aantal medewerkers
111
Nieuwsartikelen
Van webbronnen en nieuwspartners
Vietnam.vn
·
22 uur geleden
De S&P 500 kende de scherpste wekelijkse daling sinds juni 2026.
Blockchain Stories
·
16 uur geleden
S&P 500 stijgt 11,6% dit jaar, maar angst domineert de markt
MarketScreener Nederland
·
1 dag geleden
Nasdaq beëindigt reeks van vier wekelijkse winsten door uitverkoop in technologiesector
Invezz
·
1 dag geleden
Dow opent 240 punten hoger terwijl AI-aandelen dalen en inflatiezorgen drukken
Profiel
Cordlife Group Limited, is a consumer health company incorporated in May 2001 and a provider of cord blood and cord lining banking services in Asia. Cordlife has been listed on the mainboard of SGX since March 2012.
Cordlife Group owns the largest network of cord blood banks in Asia with full stem cell processing and storage facilities in six markets including Singapore, Hong Kong, India, Indonesia, and the Philippines. Beyond cord blood and cord lining banking, Cordlife offers diagnostics services, particularly for the mother and child segment, including urine-based newborn metabolic screening, non-invasive prenatal testing, paediatric vision screening and family genetic screening services.
Cordlife's stem cell processing and storage facilities in Singapore, Hong Kong, India, Indonesia, the Philippines and Malaysia were accredited by AABB until 2024 when its accreditation was withdrawn.
In November 2023, the Ministry of Health of Singapore revealed that Cordlife Group had exposed cryopreserved cord blood units at suboptimal temperatures, damaging the cord blood units belonging to at least 2,150 clients and rendering them unsuitable for stem cell transplant purposes. Wikipedia
Over Cordlife Group Ltd